शेयर मूल्य

तारीख	Hansoh Pharmaceutical Group Company राजस्व	Hansoh Pharmaceutical Group Company EBIT	Hansoh Pharmaceutical Group Company लाभ
2029e	17.61 अरब undefined	0 undefined	0 undefined
2028e	16.25 अरब undefined	5.61 अरब undefined	0 undefined
2027e	14.91 अरब undefined	5.25 अरब undefined	0 undefined
2026e	14.13 अरब undefined	4.39 अरब undefined	4.28 अरब undefined
2025e	12.65 अरब undefined	3.89 अरब undefined	3.77 अरब undefined
2024e	12.1 अरब undefined	3.87 अरब undefined	3.77 अरब undefined
2023	10.1 अरब undefined	2.65 अरब undefined	3.28 अरब undefined
2022	9.38 अरब undefined	2.57 अरब undefined	2.58 अरब undefined
2021	9.94 अरब undefined	2.96 अरब undefined	2.71 अरब undefined
2020	8.69 अरब undefined	2.78 अरब undefined	2.57 अरब undefined
2019	8.68 अरब undefined	2.8 अरब undefined	2.56 अरब undefined
2018	7.72 अरब undefined	2.26 अरब undefined	1.9 अरब undefined
2017	6.19 अरब undefined	1.91 अरब undefined	1.6 अरब undefined
2016	5.43 अरब undefined	1.79 अरब undefined	1.48 अरब undefined

	राजस्व	EBIT	लाभ
2016	5.43 अरब CNY	1.79 अरब CNY	1.48 अरब CNY
2017	6.19 अरब CNY	1.91 अरब CNY	1.6 अरब CNY
2018	7.72 अरब CNY	2.26 अरब CNY	1.9 अरब CNY
2019	8.68 अरब CNY	2.8 अरब CNY	2.56 अरब CNY
2020	8.69 अरब CNY	2.78 अरब CNY	2.57 अरब CNY
2021	9.94 अरब CNY	2.96 अरब CNY	2.71 अरब CNY
2022	9.38 अरब CNY	2.57 अरब CNY	2.58 अरब CNY
2023	10.1 अरब CNY	2.65 अरब CNY	3.28 अरब CNY
2024e	12.1 अरब CNY	3.87 अरब CNY	3.77 अरब CNY
2025e	12.65 अरब CNY	3.89 अरब CNY	3.77 अरब CNY
2026e	14.13 अरब CNY	4.39 अरब CNY	4.28 अरब CNY
2027e	14.91 अरब CNY	5.25 अरब CNY	0 CNY
2028e	16.25 अरब CNY	5.61 अरब CNY	0 CNY
2029e	17.61 अरब CNY	0 CNY	0 CNY

2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e	2027e	2028e	2029e
5.43	6.19	7.72	8.68	8.69	9.94	9.38	10.1	12.1	12.65	14.13	14.91	16.25	17.61
-	13.86	24.85	12.43	0.09	14.33	-5.57	7.68	19.80	4.48	11.78	5.51	8.98	8.38
92.69	92.64	92.19	91.60	90.75	91.23	90.73	89.79	-	-	-	-	-	-
5.04	5.73	7.12	7.95	7.89	9.06	8.51	9.07	0	0	0	0	0	0
1.79	1.91	2.26	2.8	2.78	2.96	2.57	2.65	3.87	3.89	4.39	5.25	5.61	0
32.90	30.95	29.20	32.22	32.03	29.78	27.34	26.19	31.96	30.77	31.03	35.17	34.49	-
1.48	1.6	1.9	2.56	2.57	2.71	2.58	3.28	3.77	3.77	4.28	0	0	0
-	8.06	19.31	34.31	0.47	5.61	-4.76	26.87	14.89	0.24	13.51	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-
5.16	5.16	5.16	5.48	5.88	6	5.93	6.02	0	0	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-

2016	2017	2018	2019	2020	2021	2022
1.8	1.93	2.31	3	3.1	3.3	2.95
119	135	156	201	233	278	344
0	0	0	0	0	0	0
-669	-644	-350	291	-806	-747	-629
-6	-21	-43	-163	-134	-253	77
3	0	0	0	0	0	0
311	231	306	541	590	319	324
1.25	1.4	2.07	3.33	2.39	2.58	2.74
-238	-256	-381	-592	-1,427	-460	-272
829	-614	-1,388	-7,075	-2,874	-2,259	-5,935
1.07	-0.36	-1.01	-6.48	-1.45	-1.8	-5.66
0	0	0	0	0	0	0
-0.05	0	0	-0.04	-0.01	3.84	-0.04
1.3	0	0	9.53	3.17	-0.04	-0.06
-2.05	-0.73	0	7.99	-1.04	3.42	-0.82
-3,301.00	-730.00	-	-	-	-	-
0	0	0	-1,500	-4,200	-380	-712
0.05	0.06	0.7	4.38	-2.28	3.66	-4.05
1,007.58	1,145.91	1,690.85	2,737.21	962.83	2,117.03	2,468.38
0	0	0	0	0	0	0

Hansoh Pharmaceutical Group Company सकल मार्जिन	Hansoh Pharmaceutical Group Company लाभ मार्जिन	Hansoh Pharmaceutical Group Company EBIT मार्जिन	Hansoh Pharmaceutical Group Company लाभ मार्जिन
2029e	89.78 %	0 %	0 %
2028e	89.78 %	34.49 %	0 %
2027e	89.78 %	35.17 %	0 %
2026e	89.78 %	31.03 %	30.31 %
2025e	89.78 %	30.77 %	29.85 %
2024e	89.78 %	31.96 %	31.11 %
2023	89.78 %	26.19 %	32.44 %
2022	90.73 %	27.34 %	27.54 %
2021	91.24 %	29.79 %	27.31 %
2020	90.76 %	32.03 %	29.56 %
2019	91.6 %	32.22 %	29.45 %
2018	92.19 %	29.21 %	24.64 %
2017	92.64 %	30.95 %	25.79 %
2016	92.69 %	32.89 %	27.17 %

	सकल मार्जिन	EBIT मार्जिन	लाभ मार्जिन
2016	92.69 %	32.89 %	27.17 %
2017	92.64 %	30.95 %	25.79 %
2018	92.19 %	29.21 %	24.64 %
2019	91.6 %	32.22 %	29.45 %
2020	90.76 %	32.03 %	29.56 %
2021	91.24 %	29.79 %	27.31 %
2022	90.73 %	27.34 %	27.54 %
2023	89.78 %	26.19 %	32.44 %
2024e	89.78 %	31.96 %	31.11 %
2025e	89.78 %	30.77 %	29.85 %
2026e	89.78 %	31.03 %	30.31 %
2027e	89.78 %	35.17 %	0 %
2028e	89.78 %	34.49 %	0 %
2029e	89.78 %	0 %	0 %

तारीख	Hansoh Pharmaceutical Group Company प्रति शेयर बिक्री	Hansoh Pharmaceutical Group Company EBIT प्रति शेयर	Hansoh Pharmaceutical Group Company प्रति शेयर लाभ
2029e	2.97 undefined	0 undefined	0 undefined
2028e	2.74 undefined	0 undefined	0 undefined
2027e	2.52 undefined	0 undefined	0 undefined
2026e	2.39 undefined	0 undefined	0.72 undefined
2025e	2.13 undefined	0 undefined	0.64 undefined
2024e	2.04 undefined	0 undefined	0.64 undefined
2023	1.68 undefined	0.44 undefined	0.54 undefined
2022	1.58 undefined	0.43 undefined	0.44 undefined
2021	1.66 undefined	0.49 undefined	0.45 undefined
2020	1.48 undefined	0.47 undefined	0.44 undefined
2019	1.59 undefined	0.51 undefined	0.47 undefined
2018	1.5 undefined	0.44 undefined	0.37 undefined
2017	1.2 undefined	0.37 undefined	0.31 undefined
2016	1.05 undefined	0.35 undefined	0.29 undefined

	प्रति शेयर बिक्री	EBIT प्रति शेयर	प्रति शेयर लाभ
2016	1.05 CNY	0.35 CNY	0.29 CNY
2017	1.2 CNY	0.37 CNY	0.31 CNY
2018	1.5 CNY	0.44 CNY	0.37 CNY
2019	1.59 CNY	0.51 CNY	0.47 CNY
2020	1.48 CNY	0.47 CNY	0.44 CNY
2021	1.66 CNY	0.49 CNY	0.45 CNY
2022	1.58 CNY	0.43 CNY	0.44 CNY
2023	1.68 CNY	0.44 CNY	0.54 CNY
2024e	2.04 CNY	0 CNY	0.64 CNY
2025e	2.13 CNY	0 CNY	0.64 CNY
2026e	2.39 CNY	0 CNY	0.72 CNY
2027e	2.52 CNY	0 CNY	0 CNY
2028e	2.74 CNY	0 CNY	0 CNY
2029e	2.97 CNY	0 CNY	0 CNY

	अंश की संख्या
2016	5.16 अरब Aktien
2017	5.16 अरब Aktien
2018	5.16 अरब Aktien
2019	5.48 अरब Aktien
2020	5.88 अरब Aktien
2021	6 अरब Aktien
2022	5.93 अरब Aktien
2023	6.02 अरब Aktien
2024e	6.02 अरब Aktien
2025e	6.02 अरब Aktien
2026e	6.02 अरब Aktien
2027e	6.02 अरब Aktien
2028e	6.02 अरब Aktien
2029e	6.02 अरब Aktien

तारीख	Hansoh Pharmaceutical Group Company लाभांश
2029e	0.2 undefined
2028e	0.2 undefined
2027e	0.2 undefined
2026e	0.21 undefined
2025e	0.2 undefined
2024e	0.21 undefined
2023	0.19 undefined
2022	0.23 undefined
2021	0.08 undefined

	लाभांश	डिविडेंड (अनुमान)
2016	0 CNY	0 CNY
2017	0 CNY	0 CNY
2018	0 CNY	0 CNY
2019	0 CNY	0 CNY
2020	0 CNY	0 CNY
2021	0.08 CNY	0 CNY
2022	0.23 CNY	0 CNY
2023	0.19 CNY	0 CNY
2024e	0 CNY	0.21 CNY
2025e	0 CNY	0.2 CNY
2026e	0 CNY	0.21 CNY
2027e	0 CNY	0.2 CNY
2028e	0 CNY	0.2 CNY
2029e	0 CNY	0.2 CNY

तारीख	Hansoh Pharmaceutical Group Company वितरण अनुपात
2029e	37.8 %
2028e	38.6 %
2027e	37.72 %
2026e	37.07 %
2025e	41 %
2024e	35.1 %
2023	35.1 %
2022	52.78 %
2021	17.43 %
2020	35.1 %
2019	35.1 %
2018	35.1 %
2017	35.1 %
2016	35.1 %

	वितरण अनुपात
2016	35.1 %
2017	35.1 %
2018	35.1 %
2019	35.1 %
2020	35.1 %
2021	17.43 %
2022	52.78 %
2023	35.1 %
2024e	35.1 %
2025e	41 %
2026e	37.07 %
2027e	37.72 %
2028e	38.6 %
2029e	37.8 %

%	नाम	शेयर	परिवर्तन	तारीख
65.81 %	Zhong (Huijuan)	3,90,00,00,000	0	29/4/2023
16.03 %	Cen (Junda)	95,00,00,000	0	1/9/2023
1.92 %	Fidelity Management & Research Company LLC	11,39,65,695	1,17,77,867	29/2/2024
0.53 %	The Vanguard Group, Inc.	3,13,43,444	-3,60,000	31/3/2024
0.50 %	FIL Investment Management (Hong Kong) Limited	2,97,35,359	-17,57,555	29/2/2024
0.46 %	UBS Asset Management (Hong Kong) Limited	2,75,23,481	-22,000	31/12/2023
0.41 %	BlackRock Institutional Trust Company, N.A.	2,40,52,609	-2,50,000	31/3/2024
0.35 %	Federated Hermes International	2,07,00,249	2,43,568	31/12/2023
0.34 %	FIL Investment Management (Singapore) Ltd.	2,02,95,197	-28,10,023	29/2/2024
0.32 %	Bosera Asset Management Co., Ltd.	1,90,32,000	46,72,000	31/12/2023
0.30 %	Hang Seng Investment Management Ltd.	1,78,48,002	-2,39,454	31/3/2024
0.28 %	Fidelity International	1,63,61,328	-8,67,816	29/2/2024
0.26 %	BlackRock Advisors (UK) Limited	1,53,44,000	4,46,000	31/3/2024
0.24 %	GF Fund Management Co., Ltd.	1,43,58,000	87,92,000	31/12/2023
0.23 %	State Street Global Advisors Asia Ltd.	1,33,65,578	52,380	31/10/2023
0.22 %	APG Asset Management N.V.	1,31,97,027	1,20,46,080	30/9/2023
0.19 %	ZhongGeng Fund Management Co., Ltd.	1,13,28,000	67,58,000	30/6/2023
0.18 %	Norges Bank Investment Management (NBIM)	1,07,86,186	-30,33,404	31/12/2023
0.15 %	China Asset Management Co., Ltd.	87,00,000	34,14,156	31/12/2023
0.11 %	E Fund Management Co. Ltd.	63,48,000	49,70,000	31/12/2023
0.09 %	Geode Capital Management, L.L.C.	55,30,000	2,98,000	29/2/2024
0.08 %	HuaAn Fund Management Co., Ltd.	48,34,000	48,12,000	31/12/2023
0.08 %	Dimensional Fund Advisors, L.P.	47,50,000	0	31/3/2024
0.08 %	Pictet Asset Management Ltd.	44,80,000	-86,000	31/12/2023
0.06 %	Amundi Asset Management, SAS	37,66,000	1,60,000	31/3/2024
0.06 %	Northern Trust Global Investments Limited	34,19,084	0	29/2/2024
0.06 %	UBS Asset Management (UK) Ltd.	33,24,970	-84,000	31/3/2024
0.05 %	Royal London Asset Management Ltd.	32,08,000	0	31/12/2023
0.05 %	JPMorgan Asset Management (Asia Pacific) Limited	30,72,000	3,54,000	29/2/2024
0.05 %	Royal London Asset Management (CIS) Limited_NLE	27,82,000	0	31/8/2023
0.04 %	CPP Investment Board	25,93,000	25,93,000	31/3/2023
0.04 %	INVESCO Asset Management Limited	25,64,000	-4,000	31/12/2023
0.04 %	Essence Fund Management Co., Ltd.	24,54,000	24,44,000	31/12/2023
0.04 %	Aviva Investors Global Services Limited	20,89,778	-2,12,884	29/2/2024
0.03 %	Credit Suisse Funds AG	20,64,000	54,000	31/3/2024
0.03 %	China Universal Asset Management Co., Ltd.	18,68,000	6,78,000	31/12/2023
0.03 %	Nuveen LLC	18,03,582	1,162	31/3/2024
0.03 %	Amundi Japan Ltd.	17,50,000	-24,000	31/3/2024
0.03 %	BlackRock (Singapore) Limited	17,21,321	4,27,474	31/3/2024
0.03 %	China Asset Management (Hong Kong) Limited	15,78,505	-83,236	31/3/2024
0.03 %	State Street Global Advisors (US)	15,54,087	-50,000	31/3/2024
0.03 %	DWS Investment GmbH	15,40,144	37,391	31/3/2024
0.03 %	CSOP Asset Management Limited	14,88,729	31,703	31/3/2024
0.03 %	Harvest Fund Management Co., Ltd.	14,86,000	2,52,000	31/12/2023
0.02 %	State Street Global Advisors (UK) Ltd.	14,37,980	2	31/3/2024
0.02 %	DWS Investments UK Limited	14,37,610	23,085	31/3/2024
0.02 %	Charles Schwab Investment Management, Inc.	12,67,724	0	31/3/2024
0.02 %	Penghua Fund Management Co., Ltd.	12,62,000	2,00,000	31/12/2023
0.02 %	Mirae Asset Global Investments (Hong Kong) Limited	11,22,286	2,41,242	31/3/2024
0.02 %	HSBC Global Asset Management (UK) Limited	10,81,556	-57,563	29/2/2024
0.02 %	Storebrand Kapitalforvaltning AS	10,54,602	26,000	29/2/2024
0.02 %	BlackRock Investment Management (UK) Ltd.	10,52,000	-74,000	29/2/2024
0.02 %	Handelsbanken Kapitalförvaltning AB	10,08,000	72,000	31/3/2024
0.02 %	Fullgoal Fund Management Co., Ltd.	9,72,000	7,42,000	31/12/2023
0.02 %	Lyu (Aifeng)	9,55,500	90,000	15/6/2023
0.02 %	KLP Fondsforvaltning AS	9,34,000	0	29/2/2024
0.02 %	GAM International Management Ltd.	9,00,000	0	29/2/2024
0.01 %	UBS Asset Management (Switzerland)	8,88,000	0	29/2/2024
0.01 %	Irish Life Investment Managers Ltd.	8,60,900	-3,100	31/3/2024
0.01 %	PGGM Vermogensbeheer B.V.	8,59,328	3,043	31/7/2023
0.01 %	Bank of China Investment Management Co., Ltd.	8,56,000	6,20,000	30/6/2023
0.01 %	Goldman Sachs Advisors B.V._NLE	8,22,000	56,000	30/11/2023
0.01 %	Zürcher Kantonalbank (Asset Management)	7,80,480	2,20,000	29/2/2024
0.01 %	Mercer Global Investments Management Ltd	7,77,809	0	31/3/2024
0.01 %	China Southern Asset Management Co. Ltd.	7,60,000	2,28,000	31/12/2023
0.01 %	American Century Investment Management, Inc.	7,50,000	1,28,000	31/3/2024
0.01 %	Mellon Investments Corporation	7,38,100	1,22,000	31/3/2024
0.01 %	Dimensional Fund Advisors, Ltd.	7,04,000	0	29/2/2024
0.01 %	Lazard Asset Management, L.L.C.	6,96,000	0	31/12/2023
0.01 %	Baoying Fund Management Co., Ltd.	6,22,719	6,22,719	31/12/2023
0.01 %	BOCI-Prudential Asset Management Ltd.	5,86,744	0	29/2/2024
0.01 %	Robeco Institutional Asset Management B.V.	5,44,000	3,90,000	29/2/2024
0.01 %	Legal & General Investment Management Ltd.	5,40,000	-64,000	29/2/2024
0.01 %	Northern Trust Investments, Inc.	5,30,000	-8,000	31/3/2024
0.01 %	Tianhong Asset Management Co., Ltd.	5,26,000	2,34,000	31/12/2023
0.01 %	Yinhua Fund Management Co., Ltd.	4,82,000	3,02,000	31/12/2023
0.01 %	British Columbia Investment Management Corp.	4,81,158	-15,539	31/3/2023
0.01 %	Cardano Asset Management NV	4,75,137	55	29/2/2024
0.01 %	GAM (Luxembourg) S.A.	4,50,000	-1,00,000	29/2/2024
0.01 %	California State Teachers Retirement System	4,42,000	-90,000	30/6/2023
0.01 %	Swedbank Robur Fonder AB	4,24,000	-22,000	29/2/2024
0.01 %	BMO Asset Management Inc.	4,19,440	0	31/3/2024
0.01 %	Sun (Yuan)	4,08,100	4,08,100	29/4/2023
0.01 %	Maxwealth Fund Management Co., Ltd.	4,00,000	4,00,000	30/6/2023
0.01 %	Bellevue Asset Management AG	4,00,000	1,00,000	29/2/2024
0.01 %	Eurizon Capital S.A.	3,86,393	6,254	29/2/2024
0.01 %	Hony Horizon Fund Management Co., Ltd.	3,86,000	3,86,000	31/12/2023
0.01 %	Mirae Asset Global Investments (USA) LLC	3,47,943	6,000	31/3/2024
0.01 %	Hwabao WP Fund Management Co., Ltd.	3,40,000	1,54,000	31/12/2023
0.01 %	Morgan Stanley Investment Management (China) Company Limited.	3,38,000	3,38,000	31/12/2023
0.01 %	Krane Funds Advisors, LLC	3,36,000	0	31/3/2024
0.01 %	UBS Asset Management Switzerland AG	3,34,000	0	29/2/2024
0.01 %	Nykredit Bank AS	3,26,000	86,000	29/2/2024
0.01 %	Vestcor Inc	3,14,081	-1,58,824	31/12/2022
0.01 %	Guliver Anlageberatung GmbH	3,06,000	64,000	31/1/2024
0.00 %	Vanguard Investments Australia Ltd.	2,95,611	151	29/2/2024
0.00 %	OP Varainhoito Oy	2,86,000	0	29/2/2024
0.00 %	Huatai-PineBridge Fund Management Co., Ltd.	2,68,630	20,000	31/12/2023
0.00 %	Degroof Petercam Asset Management	2,62,269	0	31/12/2023
0.00 %	Oberweis Asset Management, Inc.	2,50,000	2,50,000	31/12/2023

What values and corporate philosophy does Hansoh Pharmaceutical Group Company represent?

Hansoh Pharmaceutical Group Co Ltd represents values of innovation, quality, and patient-centricity. With a strong corporate philosophy, the company focuses on developing and delivering high-quality pharmaceutical products that improve and save lives. Hansoh Pharmaceutical Group Co Ltd's commitment to innovation drives the development of new and effective therapies to address unmet medical needs. The company's patient-centric approach ensures that their products are developed and manufactured with the highest quality standards, aiming to provide optimal healthcare solutions for patients worldwide. Hansoh Pharmaceutical Group Co Ltd's dedication to excellence makes them a trusted and reliable player in the pharmaceutical industry.

In which countries and regions is Hansoh Pharmaceutical Group Company primarily present?

Hansoh Pharmaceutical Group Co Ltd is primarily present in China.

What significant milestones has the company Hansoh Pharmaceutical Group Company achieved?

Hansoh Pharmaceutical Group Co Ltd has achieved several significant milestones. In recent years, the company successfully completed its initial public offering (IPO) on the Hong Kong Stock Exchange, marking a major milestone in its financial development. Additionally, Hansoh Pharmaceutical Group has made significant advancements in its research and development efforts, resulting in the successful launch of innovative and high-quality pharmaceutical products. The company has also expanded its global footprint by establishing strategic collaborations and partnerships with international pharmaceutical companies. Overall, Hansoh Pharmaceutical Group Co Ltd continues to make notable strides in the pharmaceutical industry, solidifying its position as a leading player in the market.

What is the history and background of the company Hansoh Pharmaceutical Group Company?

Hansoh Pharmaceutical Group Co Ltd is a leading pharmaceutical company with a rich history and background. Founded in 1995, the company has rapidly grown to become one of the largest and most respected pharmaceutical companies in China. Hansoh Pharmaceutical focuses on the research, development, manufacturing, and commercialization of innovative drugs in various therapeutic areas like oncology, diabetes, and cardiovascular diseases. With a strong emphasis on innovation and quality, Hansoh Pharmaceutical has successfully introduced numerous blockbuster drugs, gaining recognition both domestically and internationally. The company's commitment to excellence and patient care has established it as a trusted name in the pharmaceutical industry.

Who are the main competitors of Hansoh Pharmaceutical Group Company in the market?

The main competitors of Hansoh Pharmaceutical Group Co Ltd in the market include well-known pharmaceutical companies such as Shanghai Pharmaceuticals Holding Co Ltd, Jiangsu Hengrui Medicine Co Ltd, and Sino Biopharmaceutical Ltd. These companies compete with Hansoh Pharmaceutical Group Co Ltd in terms of research and development, product portfolio, market presence, and overall performance in the pharmaceutical industry.

In which industries is Hansoh Pharmaceutical Group Company primarily active?

Hansoh Pharmaceutical Group Co Ltd primarily operates in the pharmaceutical industry.

What is the business model of Hansoh Pharmaceutical Group Company?

The business model of Hansoh Pharmaceutical Group Co Ltd is focused on research, development, manufacturing, and commercialization of innovative pharmaceutical products. As one of the leading pharmaceutical companies in China, Hansoh Pharmaceutical Group Co Ltd aims to provide high-quality and affordable medications to improve the well-being of individuals. The company collaborates with healthcare professionals and institutions to meet the evolving healthcare needs of patients. Hansoh Pharmaceutical Group Co Ltd's business model emphasizes continuous innovation, leveraging cutting-edge technology, and maintaining strong partnerships across the industry. Through its diversified portfolio and commitment to excellence, the company strives to contribute to the advancement of healthcare in China and globally.

Hansoh Pharmaceutical Group Company 2024 की कौन सी KGV है?

Hansoh Pharmaceutical Group Company का केजीवी 26.6 है।

Hansoh Pharmaceutical Group Company 2024 की केयूवी क्या है?

Hansoh Pharmaceutical Group Company KUV 8.28 है।

Hansoh Pharmaceutical Group Company का AlleAktien गुणवत्ता स्कोर क्या है?

Hansoh Pharmaceutical Group Company के लिए AlleAktien गुणवत्ता स्कोर 3/10 है।

Hansoh Pharmaceutical Group Company 2024 का वार्षिक कारोबार कितना है?

अपेक्षित Hansoh Pharmaceutical Group Company का व्यापार वोल्यूम 12.1 अरब CNY है।

Hansoh Pharmaceutical Group Company 2024 का लाभ कितना है?

अपेक्षित Hansoh Pharmaceutical Group Company लाभ 3.77 अरब CNY है।

Hansoh Pharmaceutical Group Company क्या करता है?

Hansoh Pharmaceutical Group Co Ltd is a leading Chinese pharmaceutical company specializing in research, development, production, and distribution of innovative and generic drugs. The company originated in Jiangsu province, China and operates globally today. The business model of Hansoh consists of various divisions focusing on drug development, manufacturing, distribution, and marketing. The company has a strong presence in the Asian market and is expanding its business worldwide. The divisions of Hansoh include research and development of new drugs, generics, over-the-counter products, and biological drugs. The company is renowned for its capabilities in active ingredient research, development, and manufacturing. Hansoh's products cover a wide range of therapeutic areas including oncology, cardiology, neurology, and infectious diseases. In the research and development field, Hansoh drives growth through investments in cutting-edge technologies like new drug research in collaboration with universities and research institutes, artificial intelligence and big data, as well as close cooperation with other companies. The generics division is a crucial part of Hansoh's business model. The company offers a wide range of generics, providing a cost-effective yet effective alternative to expensive brand-name products. The company works towards lowering production costs in the long term and facilitating access to medication for patients worldwide. Additionally, the company operates in the over-the-counter (OTC) sector, offering products such as vitamins, pain relievers, and non-prescription medications. Hansoh also focuses heavily on biological drugs, particularly in the field of antibody therapy. Here, the company works on developing new drugs for the treatment of cancer and other serious illnesses. To make Hansoh Pharma's business successful, the company has established a strong presence in key markets around the world. Collaboration with other pharmaceutical companies to jointly market and distribute their products is a crucial aspect. For example, Germany and the USA are important markets for the company. Overall, the business model of Hansoh Pharmaceutical Group Co Ltd is focused on the long-term sustainability and growth of their business. Through a combination of innovative development and production processes, a broad portfolio of drugs, and a strong presence in key markets worldwide, the company remains on a growth trajectory and will establish itself as a significant player in the global pharmaceutical industry in the future.

Hansoh Pharmaceutical Group Company डिविडेंड कितना है?

Hansoh Pharmaceutical Group Company एक वर्ष में बार वितरण करते हुए 0.23 CNY का डिविडेंड देता है।

Hansoh Pharmaceutical Group Company कितनी बार लाभांश देती है?

वर्तमान में Hansoh Pharmaceutical Group Company के लिए डिविडेंड की गणना नहीं की जा सकती है या फिर कंपनी डिविडेंड नहीं दे रही है।

Hansoh Pharmaceutical Group Company ISIN क्या है?

Hansoh Pharmaceutical Group Company का ISIN KYG549581067 है।

Hansoh Pharmaceutical Group Company WKN क्या है?

Hansoh Pharmaceutical Group Company का WKN A2PLRC है।

Hansoh Pharmaceutical Group Company टिकर क्या है?

Hansoh Pharmaceutical Group Company का टिकर 3692.HK है।

Hansoh Pharmaceutical Group Company कितना लाभांश देती है?

पिछले 12 महीनों में Hansoh Pharmaceutical Group Company ने 0.19 CNY का डिविडेंड भुगतान किया। यह लगभग 1.15 % के डिविडेंड यील्ड के बराबर है। आगामी 12 महीनों के लिए Hansoh Pharmaceutical Group Company अनुमानतः 0.2 CNY का डिविडेंड भुगतान करेगी।

Hansoh Pharmaceutical Group Company का डिविडेंड यील्ड कितना है?

Hansoh Pharmaceutical Group Company का वर्तमान डिविडेंड यील्ड 1.15 % है।

Hansoh Pharmaceutical Group Company कब लाभांश देगी?

Hansoh Pharmaceutical Group Company तिमाही आधार पर लाभांश का भुगतान करता है। यह अक्तूबर, जुलाई, अक्तूबर, जुलाई महीनों में वितरित किया जाता है।

Hansoh Pharmaceutical Group Company का लाभांश कितना सुरक्षित है?

Hansoh Pharmaceutical Group Company ने पिछले 0 वर्षों में हर साल डिविडेंड का भुगतान किया।

Hansoh Pharmaceutical Group Company का लाभांश कितना है?

आने वाले 12 महीनों के लिए 0.2 CNY के डिविडेंड की उम्मीद की जा रही है। यह 1.23 % के डिविडेंड यील्ड के बराबर है।

Hansoh Pharmaceutical Group Company किस सेक्टर में है?

Hansoh Pharmaceutical Group Company को 'स्वास्थ्य' क्षेत्र से संबद्ध किया गया है।

Wann musste ich die Aktien von Hansoh Pharmaceutical Group Company kaufen, um die vorherige Dividende zu erhalten?

Hansoh Pharmaceutical Group Company का आखिरी लाभांश प्राप्त करने के लिए, जो 17/7/2024 को 0.142 CNY की राशि में था, आपको Ex-दिन 19/6/2024 से पहले इसे अपनी डिपो में रखना आवश्यक था।

Hansoh Pharmaceutical Group Company ने आखिरी बार लाभांश कब भुगतान किया था?

अंतिम लाभांश का भुगतान 17/7/2024 को किया गया था।

Hansoh Pharmaceutical Group Company का लाभांश 2023 में कितना था?

2023 में Hansoh Pharmaceutical Group Company द्वारा 0.23 CNY डिविडेंड के रूप में वितरित किए गए थे।

Hansoh Pharmaceutical Group Company डिविडेंड किस मुद्रा में वितरित करता है?

Hansoh Pharmaceutical Group Company के दिविडेंड CNY में वितरित किए जाते हैं।

प्रत्यक्ष निर्गम	9,024.6
खरीदी गई ऊर्जा से संबंधित अप्रत्यक्ष उत्सर्जन	77,719.97
वर्तमान श्रृंखला में परोक्ष उत्सर्जन	—
CO₂ उत्सर्जन	86,744.57
CO₂-कमी रणनीति	✅
कोयला ऊर्जा	❌
परमाणु ऊर्जा	❌
प्रयोगशाला में जानवरों पर परीक्षण	❌
पेल्ज़ और लेदर	—
कीटनाशक	—
ताड़ का तेल	—
तंबाकू	❌
जेनेटिक इंजीनियरिंग	❌
क्लाइमाकॉन्ज़ेप्ट	—
स्थायी वानिकी	—
पुनर्चक्रण नियमन	✅
पर्यावरण के अनुकूल पैकेजिंग	✅
खतरनाक पदार्थ	✅
ईंधन खपत और दक्षता	✅
जल उपयोग और दक्षता	✅

महिला कर्मचारियों का प्रतिशत	35.769
प्रबंधन में महिलाओं की हिस्सेदारी	—
एशियाई कर्मचारियों की हिस्सेदारी	—
एशियाई प्रबंधन की हिस्सेदारी	—
हिस्पैनिक/लैटिनो कर्मचारियों का प्रतिशत	—
हिस्पैनो/लैटिनो प्रबंधन हिस्सा	—
श्वेत अधिकारियों का प्रतिशत	—
काले प्रबंधन की हिस्सेदारी	—
श्वेत कर्मचारियों का अनुपात	—
श्वेत प्रबंधन में हिस्सेदारी	—
वयस्क सामग्री	❌
अल्कोहल	❌
रक्षा	—
शस्त्र	❌
जुआ	❌
सैन्य अनुबंध	❌
मानवाधिकार अवधारणा	✅
गोपनीयता नीतи	—
काम और स्वास्थ्य सुरक्षा	✅
कैथोलिक	✅

स्थिरता रिपोर्ट	✅
स्टेकहोल्डर-इंगेजमेंट	✅
नीतियाँ वापस बुलाने की	❌
प्रतिस्पर्धा कानून	❌

बाजार	Hansoh Pharmaceutical Group Company टिकर
फ्रैंकफर्ट	3KY.F
HKSE	3692.HK
म्यूनिख	3KY.MU

Hansoh Pharmaceutical Group Company टिकर	Hansoh Pharmaceutical Group Company FIGI
3692:HK	BBG00P78Y7N1
3692EUR:XS	BBG00PG9MD40
3692EUR:XH	BBG00PG9MD77
3692EUR:XF	BBG00PG9MD95
3692EUR:XE	BBG00PG9MDC1
3692EUR:XJ	BBG00PG9MDD0
3692EUR:XL	BBG00PG9MDF8
3692EUR:XG	BBG00PG9MDG7
3692EUR:XO	BBG00PG9MDH6
3692EUR:XA	BBG00PG9MDM0
3692EUR:E1	BBG00PG9MDN9
3692EUR:XT	BBG00PG9MDP7
3692EUR:XW	BBG00PG9MDQ6
3692EUR:XU	BBG00PG9MDR5
3692EUR:XV	BBG00PG9MDS4
3692EUR:XM	BBG00PG9MDT3
3692EUR:XQ	BBG00PG9MDV0
3692EUR:XX	BBG00PG9MDW9
3692EUR:XZ	BBG00PG9MDX8
3692EUR:EU	BBG00PG9MDZ6
3KY:TH	BBG00PGKL8X5
3KY:GR	BBG00PGLT3M8
3KY:GF	BBG00PGLT3N7
3KY:GS	BBG00PGLT3R3
3KY:GM	BBG00PGLT3S2
3692HKD:EP	BBG00PH03PP9
3692HKD:EZ	BBG00PH03PR7
3692HKD:XS	BBG00PH03PS6
3692HKD:XH	BBG00PH03PW1
3692HKD:XF	BBG00PH03PY9
3692HKD:XE	BBG00PH03Q04
3692HKD:XJ	BBG00PH03Q13
3692HKD:XL	BBG00PH03Q22
3692HKD:XG	BBG00PH03Q31
3692HKD:XO	BBG00PH03Q40
3692HKD:XA	BBG00PH03Q86
3692HKD:E1	BBG00PH03Q95
3692HKD:XT	BBG00PH03QB2
3692HKD:XW	BBG00PH03QC1
3692HKD:XU	BBG00PH03QD0
3692HKD:XV	BBG00PH03QF8
3692HKD:XM	BBG00PH03QG7
3692HKD:XQ	BBG00PH03QH6
3692HKD:XX	BBG00PH03QJ4
3692HKD:XZ	BBG00PH03QK2
3692HKD:EU	BBG00PH03QN9
3692:H1	BBG00Q6WB3D2
3692:H2	BBG00Q6WBGD3
3KY:GZ	BBG00W9LMHM7
3692EUR:EP	BBG00W9LR9N9
3692EUR:EZ	BBG00W9LR9Q6
HNSPF:US	BBG00Z8393Z3
HNSPF:PQ	BBG00Z8394D5
HNSPF:UV	BBG00Z8394F3
3KY:LA	BBG018H9RRP7
3KY:LU	BBG018J3F9G1

अपने जीवन के सर्वश्रेष्ठ निवेश करें